Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CA5-C82E9 | Cynomolgus | Biotinylated Cynomolgus CA125 / MUC16 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CA5-M52H6 | Mouse | Mouse CA125 / MUC16 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
CA5-C52H8 | Cynomolgus | Cynomolgus CA125 / MUC16 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CA5-R52H3 | Rhesus macaque | Rhesus macaque CA125 / MUC16 (12664-12920) Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CA5-R52H6 | Rhesus macaque | Rhesus macaque CA125 / MUC16 (13647-14291) Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CA5-H52H6 | Human | Human CA125 / MUC16 (13810-14451) Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
CA5-H82F8 | Human | Biotinylated Human CA125 / MUC16 (13810-14451) Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
|
CA5-H82F4 | Human | Biotinylated Human CA125 / MUC16 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Biotinylated Mouse Mesothelin, His,Avitag (Cat. No. MSN-M82E7) immobilized on CM5 Chip can bind Mouse CA125 Protein, His Tag (Cat. No. CA5-M52H6) with an affinity constant of 16.4 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Oregovomab | B43.13 | Phase 3 Clinical | Paladin Pharma | Ovarian Neoplasms; Carcinoma; Abdominal Neoplasms; Carcinoma, Ovarian Epithelial; Pancreatic Neoplasms; Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Adenocarcinoma | Details |
LBL-033 | LBL-033 | Phase 2 Clinical | Nanjing Leads Biolabs Co Ltd | Neoplasms | Details |
REGN-5668 | REGN-5668 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Ovarian Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms | Details |
Ubamatamab | REGN-4018 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Ovarian Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms | Details |
PRGN-3005 | PRGN-3005 | Phase 1 Clinical | Precigen Inc | Ovarian Neoplasms; Esophageal Neoplasms; Sarcoma; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms | Details |
JCAR-020 | JCAR-020 | Phase 1 Clinical | Memorial Sloan Kettering Cancer Center, Juno Therapeutics Inc, Eureka Therapeutics Inc | Solid tumours; Neoplasms | Details |
huAR9.6-IRDye800 | University Of Nebraska Medical Center | Details |
This web search service is supported by Google Inc.